Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Christos P. Argyropoulos"'
Autor:
J. Pedro Teixeira, Lisa Saa, Kevin A. Kaucher, Ruben D. Villanueva, Michelle Shieh, Crystal R. Baca, Brittany Harmon, Zanna J. Owen, Ismael Mendez Majalca, Darren W. Schmidt, Namita Singh, Saeed K. Shaffi, Zhi Q. Xu, Thomas Roha, Jessica A. Mitchell, Sevag Demirjian, Christos P. Argyropoulos
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background On December 29, 2021, during the delta wave of the Coronavirus Disease 2019 (COVID-19) pandemic, the stock of premanufactured solutions used for continuous kidney replacement therapy (CKRT) at the University of New Mexico Hospital
Externí odkaz:
https://doaj.org/article/d4c1c385304f40679e6326cf1b6d14a8
Autor:
M. Gabriela Cabanilla, Matthew J. Briski, Zachary Bruss, Lisa Saa, Pamela C. Vasquez, Chelsea N. Rodriguez, Jessica A. Mitchell, Michael L. Bernauer, Christos P. Argyropoulos, Cameron S. Crandall, J. Pedro Teixeira
Publikováno v:
Renal Failure, Vol 45, Iss 2 (2023)
1,3-β-d-Glucan (BDG) is commonly used for diagnosing invasive fungal infections (IFIs). While exposure to cellulose-based hemodialyzers is known to cause false-positive BDG results, the impact of modern hemofilters used in continuous renal replaceme
Externí odkaz:
https://doaj.org/article/b4f903158513463fabe249226e4a7a43
Autor:
Alisa C. Illescas, Christos P. Argyropoulos, Sara A. Combs, Saeed K. Shaffi, Zhi Q. Xu, Michael A. Aragon, J. Pedro Teixeira
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract In May and June 2020, an outbreak of methanol poisoning arose in the southwest United States linked to ingestion of contaminated hand sanitizer imported during the coronavirus disease 2019 pandemic, ultimately resulting in over a dozen hospi
Externí odkaz:
https://doaj.org/article/97c188a1389d4a39a85a2a0ce6c5d1ca
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/c41f028b7c1544c1b51554afce948f8c
Autor:
Mark Rohrscheib, Ramin Sam, Dominic S. Raj, Christos P. Argyropoulos, Mark L. Unruh, Susie Q. Lew, Todd S. Ing, Nathan W. Levin, Antonios H. Tzamaloukas
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
The key message from the 1958 Edelman study states that combinations of external gains or losses of sodium, potassium and water leading to an increase of the fraction (total body sodium plus total body potassium) over total body water will raise the
Externí odkaz:
https://doaj.org/article/eee75b8d40ee4e1d91453ac5ca0fb5ed
Autor:
Vikas Ghai, Xiaogang Wu, Anjalei Bheda-Malge, Christos P. Argyropoulos, José F. Bernardo, Trevor Orchard, David Galas, Kai Wang
Publikováno v:
Kidney International Reports, Vol 3, Iss 3, Pp 555-572 (2018)
Introduction: Diabetic nephropathy (DN) is a form of progressive kidney disease that often leads to end-stage renal disease (ESRD). It is initiated by microvascular complications due to diabetes. Although microalbuminuria (MA) is the earliest clinica
Externí odkaz:
https://doaj.org/article/a338d099e4df4049bc4b1897caf70666
Autor:
Ioannis Panagoulias, Fotios Karagiannis, Ioanna Aggeletopoulou, Tassos Georgakopoulos, Christos P. Argyropoulos, Karolina Akinosoglou, Charalambos Gogos, Athanasios Skoutelis, Athanasia Mouzaki
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
HIV-1 is transcriptionally active in activated T helper (Th)-cells and inactive in naive or resting memory Th-cells. Ets-2 is a preinduction transcriptional repressor of the IL-2 gene in naive Th-cells and a candidate transcriptional repressor of HIV
Externí odkaz:
https://doaj.org/article/d2ccc2b8230e49a2a50f89540954a5a8
Autor:
Christos P. Argyropoulos, Shan Shan Chen, Yue-Harn Ng, Maria-Eleni Roumelioti, Kamran Shaffi, Pooja P. Singh, Antonios H. Tzamaloukas
Publikováno v:
Frontiers in Medicine, Vol 4 (2017)
There is currently an unmet need for better biomarkers across the spectrum of renal diseases. In this paper, we revisit the role of beta-2 microglobulin (β2M) as a biomarker in patients with chronic kidney disease and end-stage renal disease. Prior
Externí odkaz:
https://doaj.org/article/019d1732a2b74c9b9c8d8d3ec72ccb31
Publikováno v:
Journal of clinical medicine. 11(20)
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) (canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin), although initially developed as glucose-lowering drugs, provide significant beneficial effects on cardiorenal outcomes, including h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27216c8c2a897b5ae4bf34ec22ebbf85
https://pubmed.ncbi.nlm.nih.gov/36294370
https://pubmed.ncbi.nlm.nih.gov/36294370
Autor:
Saad Alshihiri, Kaushalendra Amatya, Christos P. Argyropoulos, Nathaniel Berman, Patricia Centron, Joseph Chilcot, Matthew Christian Cornelius, Scott D. Cohen, Daniel Cukor, Sabina M. De Geest, Kris Denhaerynck, Fabienne Dobbels, Kristy L. Engel, Ken Farrington, Capri G. Foy, C. Graham Ford, Nicholas A. Gray, Konstadina Griva, Stephen R. Hooper, Manisha Jhamb, Kirsten L. Johansen, Paul L. Kimmel, Kristin K. Kuntz, Norman B. Levy, Susie Q. Lew, Rajnish Mehrotra, Marva M. Moxey-Mims, Larissa Myaskovsky, Melissa S. Nataatmadja, Stanton P. Newman, Jenna M. Norton, L. Parker Gregg, Davin K. Quinn, Janette Ribaut, Maria-Eleni Roumelioti, Jennifer Steel, S. Susan Hedayati, Mark L. Unruh, Elly Varma, Connie J. Wang, John Weinman, James B. Wetmore, Alice Won
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8459a30aab399dee7ad98cf876e67318
https://doi.org/10.1016/b978-0-12-817080-9.09990-5
https://doi.org/10.1016/b978-0-12-817080-9.09990-5
